Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingnao Shuluo Tablets for Ischemic Stroke Recovery
CTR20132898Phase 2Active
- Sponsor
- Changsha Dynamic Energy Biotechnology
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xingnao Shuluo in ischemic stroke, brain infarction, sponsored by Changsha Dynamic Energy Biotechnology. Started Apr 2014; status: active.
02
Drugs
Xingnao Shuluo
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on CTR20132898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132898.